| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |